This article has Open Peer Review reports available.
Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients
© The Author(s). 2017
Received: 13 June 2017
Accepted: 12 November 2017
Published: 16 November 2017
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|13 Jun 2017||Submitted||Original manuscript|
|4 Aug 2017||Reviewed||Reviewer Report - David Rey|
|13 Sep 2017||Reviewed||Reviewer Report - Delphine Sculier|
|10 Oct 2017||Author responded||Author comments - Nicola Gianotti|
|Resubmission - Version 2|
|10 Oct 2017||Submitted||Manuscript version 2|
|27 Oct 2017||Reviewed||Reviewer Report - Delphine Sculier|
|6 Nov 2017||Author responded||Author comments - Nicola Gianotti|
|Resubmission - Version 3|
|6 Nov 2017||Submitted||Manuscript version 3|
|12 Nov 2017||Editorially accepted|
|16 Nov 2017||Article published||10.1186/s12879-017-2831-9|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.